CPD Session on Resistance to Antimalarial Drugs

NameHAMURWA HC IV
Activity TitleCPD Session on Resistance to Antimalarial Drugs
DetailsA Continuing Professional Development (CPD) session on resistance to antimalarial drugs by different malaria species was held at Hamurwa HC IV. The session focused on increasing health workers’ knowledge of the causes, patterns, and implications of antimalarial drug resistance, with emphasis on appropriate diagnosis and treatment of malaria according to the current national treatment guidelines. The discussion covered the major malaria species, particularly Plasmodium falciparum and Plasmodium malariae, ovale, Vivax and highlighted the importance of accurate diagnosis before treatment. Participants reviewed recommended antimalarial regimens, appropriate dosing, treatment of uncomplicated and severe malaria, management of treatment failure, and the importance of completing prescribed treatment. Emphasis was also placed on avoiding inappropriate use of antimalarial medicines, ensuring adherence to treatment, and promptly identifying and managing suspected drug-resistant or severe cases. The CPD provided an opportunity for health workers to refresh their knowledge, discuss challenges encountered in malaria management, and strengthen adherence to current malaria treatment protocols in order to improve patient outcomes and reduce the development and spread of antimalarial drug resistance.
CompetenceGeneral Medicine
Start Date25-09-2026
End Date25-09-2026
Event Time10:45 AM
LocationHamurwa HCIV
Cost (UGX)0
CPD Points1.5